Chemical inhibitors of transmembrane protein 238 like can interfere with the protein's function by disrupting various cellular signaling pathways and processes. W-7 Hydrochloride and KN-93 target calmodulin-dependent mechanisms, with W-7 Hydrochloride impeding calmodulin-mediated activation of calcium channels and KN-93 obstructing the activities of Ca2+/calmodulin-dependent protein kinase II, both of which are crucial in the calcium signaling pathways that transmembrane protein 238 like may utilize for its activity. BAPTA serves as a calcium chelator, sequestering calcium ions and thereby inhibiting the calcium-dependent signaling on which transmembrane protein 238 like's function could depend. Similarly, ML-7's inhibition of myosin light chain kinase may alter the cytoskeletal dynamics and cellular mechanics that are potentially necessary for transmembrane protein 238 like's operation within the cell.
Xestospongin C, Thapsigargin, and Cyclopiazonic Acid disrupt intracellular calcium stores by inhibiting the IP3 receptor and the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) respectively, leading to altered calcium homeostasis which transmembrane protein 238 like would require for its function. 2-APB's action on IP3 receptors and SOCE channels further suppresses calcium signaling, which is a pivotal aspect of transmembrane protein 238 like's activity. Nifedipine, Verapamil, and Nimodipine, as blockers of L-type calcium channels, inhibit the influx of calcium ions into the cell, a process that transmembrane protein 238 like could rely on for its activation or regulation. Dantrolene's specific inhibition of ryanodine receptors may preclude calcium release from the sarcoplasmic reticulum, which is another potential avenue for the regulation of transmembrane protein 238 like's activity within cellular signaling pathways. These inhibitors collectively demonstrate different strategies by which the function of transmembrane protein 238 like can be inhibited, targeting the intricate network of calcium signaling and cellular mechanics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
Inhibits calmodulin-dependent processes, potentially reducing calmodulin-mediated activation of certain calcium channels that transmembrane protein 238 like may require for its function. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $67.00 $262.00 | 10 | |
Acts as a calcium chelator, inhibiting calcium-dependent signaling pathways that transmembrane protein 238 like may rely on for its activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
Inhibits myosin light chain kinase, which could disrupt cytoskeletal rearrangements and cellular mechanics that transmembrane protein 238 like might need for its function. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII), a key regulator in calcium signaling pathways, which transmembrane protein 238 like may be a part of. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $500.00 | 14 | |
Inhibitor of IP3 receptor, which would block calcium release from the endoplasmic reticulum and could inhibit calcium signaling pathways involving transmembrane protein 238 like. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to disrupted calcium homeostasis, which transmembrane protein 238 like might depend on for its function. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
Inhibits IP3 receptors and store-operated calcium entry (SOCE) channels, which could suppress calcium signaling required for transmembrane protein 238 like function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Blocks L-type calcium channels, potentially inhibiting calcium influx that transmembrane protein 238 like may necessitate for its function. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Inhibits voltage-dependent L-type calcium channels, which could hinder calcium signaling pathways that transmembrane protein 238 like is associated with. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Inhibits ryanodine receptors which may block the calcium release from the sarcoplasmic reticulum, and thus could inhibit signaling mechanisms of transmembrane protein 238 like. | ||||||